2 completed, 2 not yet recruiting, 2 recruiting, 1 unknown. 3 Phase 2, 3 Phase 3, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 3 | Completed 2, Unknown 1 |
| Not applicable | 2 | Not yet recruiting 1, Recruiting 1 |
Follow TPO-RA: new trials by email Literature Review of TPO-RA trials Research Report on TPO-RA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TPO-RA Plus Baricitinib vs. TPO-RA for ITP Baricitinib, TPO-RA - ITP - Immune Thrombocytopenia | Phase 2 | Not yet recruiting | Peking University People's Hospital | 100 | 2026-07-01 | 2026-06-25 |
| Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA Romiplostim, Recombinant Human Thrombopoietin - MDS (Myelodysplastic Syndrome), Aplastic Anemia (AA) | Phase 2 | Recruiting | The First Affiliated Hospital of Soochow University | 66 | 2026-01-31 | 2026-04-15 |
| Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid Failure Ripertamab/Eltrombopag, Eltrombopag - ITP - Immune Thrombocytopenia | Not applicable | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 78 | 2025-02-01 | 2025-01-24 |
| Romiplostim in Chemotherapy-Induced Thrombocytopenia Romiplostim - Chemotherapy-induced Thrombocytopenia, Solid Malignancy | Phase 3 | Unknown | Ain Shams University | 30 | 2023-12-17 | 2024-01-11 |
| The Use of Eltrombopag Post HSCT in BMFD Eltrombopag 25 MG Oral Tablet, Supportive care - Stem Cell Transplant Complications | Phase 2 / Phase 3 | Completed | The First Affiliated Hospital of Soochow University | 118 | 2022-10-22 | 2025-12-03 |
| The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9 all-trans retinoic acid, Eltrombopag - Purpura, Thrombocytopenic, Idiopathic | Phase 3 | Completed | Peking University People's Hospital | 96 | 2022-10-12 | 2025-09-09 |
| TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years TPO-RA - Primary Immune Thrombocytopenic Purpura | Not applicable | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 100 | 2021-05-30 | 2025-02-24 |
Purpura, Thrombocytopenic, Idiopathic (3) · Anemia, Aplastic (1) · Anemia, Refractory, with Excess of Blasts (1) · Bone Marrow Failure Disorders (1) · Thrombocytopenia (1)
Peking University People's Hospital (2) · The First Affiliated Hospital of Soochow University (2) · Ain Shams University (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
China (4) · Egypt (1)
Depei Wu, PhD,MD (1) · Lei Zhang (1) · Xiaohui Zhang, MD (1)